Information
-
Trademark
-
88424870
-
International Classifications
-
Filing Date
May 10, 2019
5 years ago
-
Transaction Date
July 05, 2022
2 years ago
-
Status Date
July 04, 2022
2 years ago
-
Published for Opposition Date
October 08, 2019
4 years ago
-
Location Date
May 27, 2020
4 years ago
-
Status Code
606
-
Current Location
INTENT TO USE SECTION
Employee Name
BUTLER, MIDGE FAE
-
Attorney Docket Number
141683.18
Attorney Name
Paul J. Kennedy
Law Office Assigned Location Code
L70
-
Owners
Mark Drawing Code
4000
Mark Identification
CERECOR
Case File Statements
- GS0051: Pharmaceutical preparations for the prevention and treatment of disorders and diseases in or affecting the central nervous system; Pharmaceutical preparations for the treatment of the brain, central nervous system, and psychiatric and neurological diseases and disorders; Pharmaceutical preparations and substances for the prevention and treatment of major depressive disorder, mood disorder, psychosis, anxiety, epilepsy, sclerosis, porphyries, stroke, Huntington's disease, insomnia, Parkinson's disease, cognitive impairment; Pharmaceutical preparations for the treatment of ectoparasites, such as head lice; Steroids; Pharmaceutical preparations containing prednisolone for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system; Pharmaceutical preparations containing prednisolone for the treatment of inflammatory disorders; Pharmaceutical preparations containing prednisolone for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Medical delivery apparatus, namely, a valved holding chamber sold empty for use with metered dose inhalers; Cephalosporins; Antibiotics; Pharmaceutical preparations for the treatment of reflux, esophagitis, GERD (Gastro-Esophageal Reflux Disease), dyspepsia, heartburn, acid regurgitation, pyrosis, epigastric pain, irritative cough and dysphonia; Oral modified release, extended release, and/or sustained release pharmaceutical preparations for the drug carbinoxamine, a pharmaceutically acceptable salt thereof and/or carbinoxamine polistirex, intended for the treatment of seasonal and perennial allergic rhinitis, and other approved uses; Vitamin, mineral and fluoride preparations for human medical or nutritional uses; Nutritional preparation in the nature of nutritional supplement containing vitamins and fluoride; Pharmaceutical products and treatments for pediatric onset and rare and orphan disorders, namely, oral formulation of D-galactose for the treatment of phosphoglucomutase 1 (PGM1) deficiency (PGM1-CDG), oral formulation of D-mannose for the treatment of Mannose Phosphate Isomerase (MPI) deficiency (MPI-CDG), oral formulation of L-fucose for the treatment of Leukocyte Adhesion Deficiency Type II (LADII) (SLC35C1-CDG), nucleotide prodrug for the treatment of Deoxyguanosine Kinase (DGUOK) deficiency; Pharmaceutical products and treatments for pediatric onset and rare and orphan disorders, namely, oral formulations for the treatment of congenital disorders of glycosylation; Pharmaceutical products and treatments for pediatric onset and rare and orphan disorders, namely, oral nucleotide replacements for the treatment of Myelodysplastic Syndromes; Pharmaceutical preparations and substances for the treatment of neurogenic orthostatic hypotension (nOH) associated with neurodegenerative diseases such as Parkinson's Disease, Multiple Systems Atrophy, and Pure Autonomic Failure; Transmembrane AMPA receptor regulatory proteins (TARPs) for use as anticonvulsant agents and to modulate neurotransmission in patients with epilepsy; Oral neuro-selective adjunctive medications; Selective kappa opioid receptor (KOR) antagonist for the treatment of major depressive disorder (MDD) and for substance use disorders
Case File Event Statements
-
7/5/2022 - 2 years ago
49 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Type: MAB6
-
7/4/2022 - 2 years ago
48 - ABANDONMENT - NO USE STATEMENT FILED
Type: ABN6
-
12/3/2021 - 2 years ago
47 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
12/1/2021 - 2 years ago
46 - SOU EXTENSION 4 GRANTED
Type: EX4G
-
12/1/2021 - 2 years ago
45 - SOU EXTENSION 4 FILED
Type: EXT4
-
12/1/2021 - 2 years ago
44 - TEAS EXTENSION RECEIVED
Type: EEXT
-
9/22/2021 - 2 years ago
43 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Type: ASGN
-
5/22/2021 - 3 years ago
42 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
5/20/2021 - 3 years ago
41 - SOU EXTENSION 3 GRANTED
Type: EX3G
-
5/20/2021 - 3 years ago
40 - SOU EXTENSION 3 FILED
Type: EXT3
-
5/20/2021 - 3 years ago
39 - TEAS EXTENSION RECEIVED
Type: EEXT
-
12/8/2020 - 3 years ago
38 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
12/7/2020 - 3 years ago
37 - SOU EXTENSION 2 GRANTED
Type: EX2G
-
12/2/2020 - 3 years ago
36 - SOU EXTENSION 2 FILED
Type: EXT2
-
12/2/2020 - 3 years ago
35 - TEAS EXTENSION RECEIVED
Type: EEXT
-
6/5/2020 - 4 years ago
34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
6/3/2020 - 4 years ago
33 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
6/3/2020 - 4 years ago
32 - SOU EXTENSION 1 FILED
Type: EXT1
-
6/3/2020 - 4 years ago
31 - TEAS EXTENSION RECEIVED
Type: EEXT
-
6/2/2020 - 4 years ago
30 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
6/2/2020 - 4 years ago
29 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
6/2/2020 - 4 years ago
28 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
6/2/2020 - 4 years ago
27 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
6/2/2020 - 4 years ago
26 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
6/2/2020 - 4 years ago
25 - WITHDRAWAL OF ATTORNEY GRANTED
Type: WOAG
-
6/2/2020 - 4 years ago
24 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Type: WOAR
-
5/27/2020 - 4 years ago
23 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
5/27/2020 - 4 years ago
22 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
4/28/2020 - 4 years ago
21 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
4/28/2020 - 4 years ago
20 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
4/28/2020 - 4 years ago
19 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Type: EWAF
-
4/28/2020 - 4 years ago
18 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
4/28/2020 - 4 years ago
17 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
4/28/2020 - 4 years ago
16 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
12/3/2019 - 4 years ago
15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
10/8/2019 - 4 years ago
14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
10/8/2019 - 4 years ago
13 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
9/18/2019 - 4 years ago
12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
9/5/2019 - 5 years ago
11 - ASSIGNED TO LIE
Type: ALIE
-
9/2/2019 - 5 years ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
8/30/2019 - 5 years ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
8/30/2019 - 5 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
8/30/2019 - 5 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
8/1/2019 - 5 years ago
6 - NOTIFICATION OF PRIORITY ACTION E-MAILED
Type: GPRN
-
8/1/2019 - 5 years ago
5 - PRIORITY ACTION E-MAILED
Type: GPRA
-
8/1/2019 - 5 years ago
4 - PRIORITY ACTION WRITTEN
Type: CPRA
-
7/25/2019 - 5 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
5/25/2019 - 5 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
5/14/2019 - 5 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP